BCTX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- An independent DSMB recommended continuing BriaCell's Phase 3 study in metastatic breast cancerSep 14, 2026
- BriaCell advanced its personalized melanoma immunotherapy vaccine candidate, Bria-MEL+Aug 24, 2026
- BriaCell received FDA clearance to initiate the Bria-PROS+ clinical study in prostate cancerAug 6, 2026
- BriaCell secured scalable manufacturing support from FUJIFILM Biotechnologies for Bria-IMTJul 15, 2026
- BriaCell engaged consulting and branding firms to support commercialization and market access planning for Bria-IMTJul 8, 2026